Phase IIB TL + YCWP + DC in Melanoma

NCT02301611 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

187

Enrollment

INDUSTRY

Sponsor class

Conditions

Melanoma

Interventions

DRUG: TLPLDC
DRUG: Placebo

Sponsor

Elios Therapeutics, LLC

Collaborators

[object Object]